Articles
 News Headlines
 Journal Headlines

  Home
  Archives
  Site Map
   
May 9, 2008
 
About AIDScience
Contact Us
——
NeuroAIDS
 
 
 
 

Vol. 2, No. 13, 5 July 2002
Other Issues:
Science Special Issue:
HIV/AIDS: Therapies, vaccines, challenges
Special suite of news, commentary, and review articles covering the state of AIDS vaccine and therapy research, to mark the AIDS 2002 Conference in Barcelona:
 
Review: Diversity considerations in HIV-1 vaccine selection
Brian Gaschen, et al.
Science 296, 2354 (2002)[Full text article]
[dEbates: Submit a response to this article]
 
Policy Forum: China and AIDS—The time to act is now
Joan Kaufman and Jun Jing
Science 296, 2339 (2002)[Full text article]
[dEbates: Submit a response to this article]
 
Letter: HIV-1 diversity and vaccine development
Gary Nabel, et al.
Science 296, 2335 (2002)[Full text article]
 
News Focus:
VACCINES: Monkey puzzles
Jon Cohen
Science 296, 2325 (2002)[Full text article]
 
News Focus:
THERAPIES: Confronting the limits of success
Jon Cohen
Science 296, 2320 (2002)[Full text article]
 
[Other Science Classic Papers]
[About AIDScience articles]  [See recent AIDScience articles]
Hot News:
HIV-1 associated with erythrocytes. A report published in Lancet supports the notion of continuous viral replication even when antiretroviral treatment is successful.
Commentary: Lancet, 359(9325), 29 June 2002 [Read article]
Report: Lancet, 359(9325), 29 June 2002 [Read article]
NeuroAIDS: Cerebrospinal fluid viral load measurements and the pathogenesis of HIV Infection of the CNS. A prospective study that looks at cerebrospinal fluid HIV RNA levels as a predictor of future progression to neuropsychological impairment in HIV-infected individuals.
Editorial: Archives of Neurology 59(6), 909 (2002) [Read article]
Report: Archives of Neurology 59(6), 923 (2002) [Read article]
dEbates: Readers' online reactions
 [Go to dEbates]

ADODB.Connection error '800a0e7a'

Provider cannot be found. It may not be properly installed.

/Issues/Issue030.asp, line 100

Latest News Headlines: [What is this?]